197 related articles for article (PubMed ID: 23728144)
1. Central nervous system herpes simplex and varicella zoster virus infections in natalizumab-treated patients.
Fine AJ; Sorbello A; Kortepeter C; Scarazzini L
Clin Infect Dis; 2013 Sep; 57(6):849-52. PubMed ID: 23728144
[TBL] [Abstract][Full Text] [Related]
2. Incidence, risk factors, and implemented prophylaxis of varicella zoster virus infection, including complicated varicella zoster virus and herpes simplex virus infections, in lenalidomide-treated multiple myeloma patients.
König C; Kleber M; Reinhardt H; Knop S; Wäsch R; Engelhardt M
Ann Hematol; 2014 Mar; 93(3):479-84. PubMed ID: 24318541
[TBL] [Abstract][Full Text] [Related]
3. Incidence and clinical features of herpes simplex viruses (1 and 2) and varicella-zoster virus infections in an adult Korean population with aseptic meningitis or encephalitis.
Choi R; Kim GM; Jo IJ; Sim MS; Song KJ; Kim BJ; Na DL; Huh HJ; Kim JW; Ki CS; Lee NY
J Med Virol; 2014 Jun; 86(6):957-62. PubMed ID: 24610349
[TBL] [Abstract][Full Text] [Related]
4. Herpes simplex and varicella zoster CNS infections: clinical presentations, treatments and outcomes.
Kaewpoowat Q; Salazar L; Aguilera E; Wootton SH; Hasbun R
Infection; 2016 Jun; 44(3):337-45. PubMed ID: 26680781
[TBL] [Abstract][Full Text] [Related]
5. Herpes encephalitis during natalizumab treatment in multiple sclerosis.
Kwiatkowski A; Gallois J; Bilbault N; Calais G; Mackowiak A; Hautecoeur P
Mult Scler; 2012 Jun; 18(6):909-11. PubMed ID: 22048950
[TBL] [Abstract][Full Text] [Related]
6. Natalizumab and HSV meningitis.
Shenoy ES; Mylonakis E; Hurtado RM; Venna N
J Neurovirol; 2011 Jun; 17(3):288-90. PubMed ID: 21487835
[TBL] [Abstract][Full Text] [Related]
7. Fatal varicella-zoster virus vasculopathy associated with adalimumab therapy.
Baek W; Lee SG; Kim YS; Kim JH; Jun JB; Kim HY
Arch Neurol; 2012 Sep; 69(9):1193-6. PubMed ID: 22732856
[TBL] [Abstract][Full Text] [Related]
8. Serological evidence of increased susceptibility to varicella-zoster virus reactivation or reinfection in natalizumab-treated patients with multiple sclerosis.
Kohlmann R; Salmen A; Chan A; Knabbe C; Diekmann J; Brockmeyer N; Skaletz-Rorowski A; Michalik C; Gold R; Überla K
Mult Scler; 2015 Dec; 21(14):1823-32. PubMed ID: 25828755
[TBL] [Abstract][Full Text] [Related]
9. Seroprevalences of varicella-zoster virus, herpes simplex virus and cytomegalovirus in a cross-sectional study in Mexico.
Conde-Glez C; Lazcano-Ponce E; Rojas R; DeAntonio R; Romano-Mazzotti L; Cervantes Y; Ortega-Barria E
Vaccine; 2013 Oct; 31(44):5067-74. PubMed ID: 24021305
[TBL] [Abstract][Full Text] [Related]
10. Comparisons in the changes of clinical characteristics and cerebrospinal fluid cytokine profiles between varicella-zoster virus meningitis/encephalitis and other central nervous system infections.
Ma C; Lu Y; Zhang Q; Chen H; Zhang Q; Hu H; Song Z; Chen R; Liu D
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Oct; 47(10):1345-1354. PubMed ID: 36411685
[TBL] [Abstract][Full Text] [Related]
11. Absent anti-N-methyl-D-aspartate receptor NR1a antibodies in herpes simplex virus encephalitis and varicella zoster virus infections.
Berger B; Pytlik M; Hottenrott T; Stich O
Int J Neurosci; 2017 Feb; 127(2):109-117. PubMed ID: 26887329
[TBL] [Abstract][Full Text] [Related]
12. Varicella Zoster Associated Vasculopathy and Retinitis with Natalizumab Use in Multiple Sclerosis.
Thayer EL; Rizvi SA; Tung GA
R I Med J (2013); 2024 Jan; 107(1):26-28. PubMed ID: 38166073
[TBL] [Abstract][Full Text] [Related]
13. Varicella-zoster meningovasculitis in a multiple sclerosis patient treated with natalizumab.
Mulero P; Auger C; Parolin L; Fonseca E; Requena M; Rio J; Tintoré M; Rovira A; Montalban X
Mult Scler; 2018 Mar; 24(3):358-360. PubMed ID: 28643544
[TBL] [Abstract][Full Text] [Related]
14. Increased prevalence of varicella zoster virus DNA in cerebrospinal fluid from patients with multiple sclerosis.
Mancuso R; Delbue S; Borghi E; Pagani E; Calvo MG; Caputo D; Granieri E; Ferrante P
J Med Virol; 2007 Feb; 79(2):192-9. PubMed ID: 17177306
[TBL] [Abstract][Full Text] [Related]
15. Risk of natalizumab-associated progressive multifocal leukoencephalopathy.
Bloomgren G; Richman S; Hotermans C; Subramanyam M; Goelz S; Natarajan A; Lee S; Plavina T; Scanlon JV; Sandrock A; Bozic C
N Engl J Med; 2012 May; 366(20):1870-80. PubMed ID: 22591293
[TBL] [Abstract][Full Text] [Related]
16. Facial herpes zoster complicated by varicella zoster virus (VZV) encephalitis: The diagnostic significance of atypical lymphocytes in cerebrospinal fluid (CSF).
Cunha BA; Strollo S; Durie N; Ibrahim MS
Heart Lung; 2011; 40(2):164-7. PubMed ID: 21144586
[TBL] [Abstract][Full Text] [Related]
17. Detection of herpes simplex and varicella zoster viruses in clinical specimens using direct immunofluorescence and cell culture assays.
Meqdam MM; Todd D; Al-Abosi M
Microbios; 2001; 105(411):111-8. PubMed ID: 11393748
[TBL] [Abstract][Full Text] [Related]
18. Varicella zoster-associated retinal and central nervous system vasculitis in a patient with multiple sclerosis treated with natalizumab.
Kobeleva X; Wegner F; Brunotte I; Dadak M; Dengler R; Stangel M
J Neuroinflammation; 2014 Jan; 11():19. PubMed ID: 24479415
[TBL] [Abstract][Full Text] [Related]
19. Cryptococcal meningitis in a multiple sclerosis patient taking natalizumab.
Valenzuela RM; Pula JH; Garwacki D; Cotter J; Kattah JC
J Neurol Sci; 2014 May; 340(1-2):109-11. PubMed ID: 24680560
[TBL] [Abstract][Full Text] [Related]
20. Varicella-zoster virus CNS disease--viral load, clinical manifestations and sequels.
Persson A; Bergström T; Lindh M; Namvar L; Studahl M
J Clin Virol; 2009 Nov; 46(3):249-53. PubMed ID: 19709927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
